[Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II]. / Terapie antiremodeling: nuove strategie e prospettive future nell'insufficienza cardiaca cronica post ischemica: Parte II.
Monaldi Arch Chest Dis
; 82(4): 195-201, 2014 Dec.
Article
en It
| MEDLINE
| ID: mdl-26562985
In recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regulate the response of cardiac tissue to ischemic injury. These involve various cell types such as fibroblasts, cells of the immune system, endothelial cells, cardiomyocytes and stem cells, as well as a myriad of mediators belonging to the system of cytokines and not only. In parallel with the latest findings on post-infarct remodeling, new potential therapeutic targets are arising to halt the progression of disease. After the evaluation of the results obtained from gene therapy and stem cells, in this part we evaluate micro-RNA, post-translational modification and microspheres based therapy.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Terapia Genética
/
Remodelación Ventricular
/
Proteína HMGB1
/
MicroARNs
/
Trasplante de Células Madre
/
Insuficiencia Cardíaca
/
Infarto del Miocardio
Tipo de estudio:
Etiology_studies
Límite:
Humans
Idioma:
It
Revista:
Monaldi Arch Chest Dis
Año:
2014
Tipo del documento:
Article
Pais de publicación:
Italia